Literature DB >> 8086324

Mechanism of the vasodilatory action of nicorandil on coronary circulation in dogs.

I Nakae1, L Quan, K Hashimoto, Y Sugimoto, T Tsutamoto, M Kinoshita.   

Abstract

Nicorandil possesses hybrid properties as a nitrate and a potassium (K) channel opener. We have previously reported that large coronary arteries responded to nicorandil at low plasma concentrations, while dilatation of small coronary arteries only occurred at higher plasma concentrations (above 200 ng/ml) in chronically instrumented dogs. In this study we examined the effects of intravenous nicorandil on epicardial coronary artery diameter (CoD) and coronary blood flow (CBF) in the absence and presence of glibenclamide, a K+ channel blocker, as well as the effects of nitroglycerin and cromakalim as reference drugs. The increase in CBF induced by nicorandil and cromakalim was significantly suppressed by glibenclamide. However, the increase in CoD induced by nicorandil and nitroglycerin was not suppressed by glibenclamide. These findings suggest that nicorandil-induced dilatation of the large coronary arteries was related to its nitrate action, while nicorandil-induced dilatation of the small coronary arteries was closely related to its effect as a K+ channel opener. In addition, the former response to nicorandil occurred at low concentrations, while the latter occurred at higher concentrations.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8086324     DOI: 10.1007/bf00877102

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN: 0920-3206            Impact factor:   3.727


  24 in total

1.  Dual mechanism of the relaxing effect of nicorandil by stimulation of cyclic GMP formation and by hyperpolarization.

Authors:  W R Kukovetz; S Holzmann; C Braida; G Pöch
Journal:  J Cardiovasc Pharmacol       Date:  1991-04       Impact factor: 3.105

2.  The effects of BRL 34915 and nicorandil on electrical and mechanical activity and on 86Rb efflux in rat blood vessels.

Authors:  S W Weir; A H Weston
Journal:  Br J Pharmacol       Date:  1986-05       Impact factor: 8.739

3.  The receptor for antidiabetic sulfonylureas controls the activity of the ATP-modulated K+ channel in insulin-secreting cells.

Authors:  H Schmid-Antomarchi; J De Weille; M Fosset; M Lazdunski
Journal:  J Biol Chem       Date:  1987-11-25       Impact factor: 5.157

Review 4.  Similarity and dissimilarity in the mode and mechanism of action between nicorandil and classical nitrates: an overview.

Authors:  N Taira
Journal:  J Cardiovasc Pharmacol       Date:  1987       Impact factor: 3.105

5.  The effects of nicorandil on phasic contractions of isolated canine coronary artery.

Authors:  Y Uchida; T Sugimoto
Journal:  J Cardiovasc Pharmacol       Date:  1987       Impact factor: 3.105

6.  A digital sonomicrometer for two-point length and velocity measurements.

Authors:  C A Goodman; F S Castellana
Journal:  Am J Physiol       Date:  1982-10

7.  Nicorandil-induced vasorelaxation: functional evidence for K+ channel-dependent and cyclic GMP-dependent components in a single vascular preparation.

Authors:  K D Meisheri; L A Cipkus-Dubray; J M Hosner; S A Khan
Journal:  J Cardiovasc Pharmacol       Date:  1991-06       Impact factor: 3.105

8.  Nicorandil increases coronary blood flow predominantly by K-channel opening mechanism.

Authors:  F Yoneyama; K Satoh; N Taira
Journal:  Cardiovasc Drugs Ther       Date:  1990-08       Impact factor: 3.727

9.  Effects of potassium channel openers on single potassium channels in mouse skeletal muscle.

Authors:  R Weik; B Neumcke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-09       Impact factor: 3.000

10.  Differential antagonism by glibenclamide of the relaxant effects of cromakalim, pinacidil and nicorandil on canine large coronary arteries.

Authors:  K Satoh; H Yamada; N Taira
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-01       Impact factor: 3.000

View more
  7 in total

1.  Intravenous nicorandil versus adenosine for fractional flow reserve measurement: a crossover, randomized study.

Authors:  Takeshi Nishi; Hideki Kitahara; Yoshihide Fujimoto; Takashi Nakayama; Kengo Nagashima; Hideki Hanaoka; Yoshio Kobayashi
Journal:  Heart Vessels       Date:  2018-06-01       Impact factor: 2.037

2.  Tilisolol hydrochloride dilates coronary arteries through an ATP-sensitive K(+)-channel opening mechanism in dogs.

Authors:  Q Liu; I Nakae; M Takahashi; A Takaoka; M Kinoshita
Journal:  Cardiovasc Drugs Ther       Date:  1996-03       Impact factor: 3.727

3.  The effect of nicorandil on small intestinal ischemia-reperfusion injury in a canine model.

Authors:  Yujin Suto; Kiyohiro Oshima; Kazuhisa Arakawa; Hiroaki Sato; Hodaka Yamazaki; Koshi Matsumoto; Izumi Takeyoshi
Journal:  Dig Dis Sci       Date:  2011-03-01       Impact factor: 3.199

Review 4.  Use of nicorandil in cardiovascular disease and its optimization.

Authors:  Shigeo Horinaka
Journal:  Drugs       Date:  2011-06-18       Impact factor: 9.546

5.  Diverticular fistulation is associated with nicorandil usage.

Authors:  James McDaid; Claire Reichl; Ihsan Hamzah; Samantha Fitter; Laura Harbach; Adrian P Savage
Journal:  Ann R Coll Surg Engl       Date:  2010-09       Impact factor: 1.951

6.  Efficacy of intravenous nicorandil for fractional flow reserve assessment: study protocol for a crossover randomised trial.

Authors:  Takeshi Nishi; Hideki Kitahara; Yoshihide Fujimoto; Takashi Nakayama; Kazumasa Sugimoto; Kengo Nagashima; Hideki Hanaoka; Yoshio Kobayashi
Journal:  BMJ Open       Date:  2016-11-21       Impact factor: 2.692

7.  Nicorandil was an Effective Treatment Option for a Patient with Bland-White-Garland Syndrome.

Authors:  Shun Morishita; Hirofumi Maeba; Kazuya Takehana; Ichiro Shiojima
Journal:  Intern Med       Date:  2017-08-10       Impact factor: 1.271

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.